Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gui-Fu-Di-Huang Pill is a classic Traditional Chinese Medicine (TCM) formula composed of eight herbal ingredients, primarily used to warm and tonify Kidney Yang. It is a modification of the Liu Wei Di Huang Wan (Six-Ingredient Rehmannia Pill) formula, with the addition of *Cinnamomum cassia* (Rou Gui) and *Aconitum carmichaelii* (Zhi Fu Zi). In modern clinical research, it is being investigated as an adjunctive therapy to selective serotonin reuptake inhibitors (SSRIs) like escitalopram for the treatment of depressive disorder, specifically targeting hypodynamic symptoms such as fatigue and lack of energy in patients with a "Yang-deficiency" constitution. The formula is hypothesized to restore metabolic and endocrine balance by modulating the hypothalamic-pituitary-adrenal (HPA) axis and warming the "Gate of Vitality" (Ming Men) in TCM terms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gui-Fu-Di-Huang Pill.